"Patient voice should not be something we add at the end of the process. We should acutally shape the entire process, from the beginning, with the patient."

Key leaders of EMBARC (the European Multicentre Audit and Research Collaboration) Amelia Shoemark and Stefano Aliberti join Guido Marchi in a podcast focusing on the latest ERS Monograph: Bronchiectasis. Guido, who is the Early Career Member representative for the Monograph, asks Stefano and Amelia about the foundation of EMBARC and its increasing international reach, better integration of the patient voice, the impact of the 2025 European Respiratory Society (ERS) bronchiectasis guidelines, and the turning point in treatment that dipeptidyl peptidase-1 (DPP-1) offers.